Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Hubei Fuxing Science and TechnologyLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Hubei Fuxing Science and TechnologyLtd şirketinin toplam hissedar öz sermayesi CN¥13.1B ve toplam borcu CN¥7.4B olup, bu da borç-öz sermaye oranını 56.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥36.2B ve CN¥23.1B dir. Hubei Fuxing Science and TechnologyLtd 'in FAVÖK'ü CN¥512.9M faiz karşılama oranı 2.3 dur. Şirketin CN¥1.5B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

56.5%

Borç/özkaynak oranı

CN¥7.39b

Borç

Faiz karşılama oranı	2.3x
Nakit	CN¥1.51b
Eşitlik	CN¥13.08b
Toplam yükümlülükler	CN¥23.09b
Toplam varlıklar	CN¥36.17b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

There's No Escaping Hubei Fuxing Science and Technology Co.,Ltd's (SZSE:000926) Muted Revenues Despite A 28% Share Price Rise

Sep 27

Why Hubei Fuxing Science and TechnologyLtd's (SZSE:000926) Shaky Earnings Are Just The Beginning Of Its Problems

Sep 06

Should You Think About Buying Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) Now?

May 22

Hubei Fuxing Science and Technology Co.,Ltd's (SZSE:000926) Share Price Could Signal Some Risk

Apr 17

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 000926 'nin kısa vadeli varlıkları ( CN¥25.8B ) kısa vadeli yükümlülüklerini ( CN¥17.4B ) aşıyor.

Uzun Vadeli Yükümlülükler: 000926 şirketinin kısa vadeli varlıkları ( CN¥25.8B ) uzun vadeli yükümlülüklerini ( CN¥5.7B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 000926 'nin net borç/öz sermaye oranı ( 44.9% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 000926 'nin borç/öz sermaye oranı son 5 yılda 180.2% seviyesinden 56.5% seviyesine düştü.

Borç Kapsamı: 000926 'nin borcu işletme nakit akışı ( 0.5% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 000926 'in borcuna ilişkin faiz ödemeleri EBIT ( 2.3 x kapsam) tarafından iyi karşılanmıyor.

Hubei Fuxing Science and TechnologyLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Hubei Fuxing Science and Technology Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024

There's No Escaping Hubei Fuxing Science and Technology Co.,Ltd's (SZSE:000926) Muted Revenues Despite A 28% Share Price Rise

New minor risk - Share price stability

New major risk - Financial position

Why Hubei Fuxing Science and TechnologyLtd's (SZSE:000926) Shaky Earnings Are Just The Beginning Of Its Problems

Second quarter 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.025 profit in 2Q 2023)

Hubei Fuxing Science and Technology Co.,Ltd Approves Election of Ke Jiuming as Director

Investor sentiment deteriorates as stock falls 20%

New major risk - Revenue and earnings growth

Hubei Fuxing Science and Technology Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 8 July 2024

Hubei Fuxing Science and Technology Co.,Ltd to Report First Half, 2024 Results on Aug 31, 2024

New major risk - Financial position

Should You Think About Buying Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) Now?

Hubei Fuxing Science and Technology Co.,Ltd, Annual General Meeting, May 31, 2024

Hubei Fuxing Science and Technology Co.,Ltd's (SZSE:000926) Share Price Could Signal Some Risk

Hubei Fuxing Science and Technology Co.,Ltd to Report Q1, 2024 Results on Apr 29, 2024

Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) announces an Equity Buyback for 40,000,000 shares, for CNY 160 million.

Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) announces an Equity Buyback for 40,000,000 shares, for CNY 160 million.

Investor sentiment deteriorates as stock falls 16%

New minor risk - Shareholder dilution

Third quarter 2023 earnings released: CN¥0.036 loss per share (vs CN¥0.014 loss in 3Q 2022)

Hubei Fuxing Science and Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 29, 2024

Less than half of directors are independent

Third quarter 2023 earnings released: EPS: CN¥0.006 (vs CN¥0.014 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.035 (vs CN¥0.04 in 2Q 2022)

Investor sentiment improves as stock rises 18%

Hubei Fuxing Science and Technology Co.,Ltd Announces Final Dividend on A Shares for the Year 2022, Payable on July 31, 2023

Hubei Fuxing Science and Technology Co.,Ltd, Annual General Meeting, Jun 02, 2023

First quarter 2023 earnings released: EPS: CN¥0.044 (vs CN¥0.04 in 1Q 2022)

Hubei Fuxing Science and Technology Co.,Ltd announced that it expects to receive CNY 1.3 billion in funding

Investor sentiment improved over the past week

High number of new directors

Third quarter 2022 earnings released: CN¥0.014 loss per share (vs CN¥0.005 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.059 in 2Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hubei Fuxing Science and Technology Co.,Ltd Announces No Dividend for 2021

Full year 2021 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2021 earnings released: CN¥0.005 loss per share (vs CN¥0.02 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.059 (vs CN¥0.13 in 2Q 2020)

Hubei Fuxing Science and Technology Co.,Ltd Approves Cash Dividend

Hubei Fuxing Science and Technology Co.,Ltd Proposes Final Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥0.32 (vs CN¥0.62 in FY 2019)

Hubei Fuxing Science and Technology Co.,Ltd(XSEC:000926) dropped from S&P Global BMI Index

New 90-day low: CN¥4.63

New 90-day low: CN¥4.77

New 90-day low: CN¥5.01

Third quarter earnings released

New 90-day low: CN¥5.23

New 90-day low: CN¥5.27

Hubei Fuxing Science and Technology Co.,Ltd announced that it expects to receive CNY 3 billion in funding

Hubei Fuxing Science and Technology Co.,Ltd announced that it has received CNY 3 billion in funding

First half earnings released

Hubei Fuxing Science and Technology Co.,Ltd to Report First Half, 2020 Results on Aug 29, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin